These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 681794)

  • 1. Isolation and characterization of protease-deficient mutants of vibrio cholerae.
    Schneider DR; Parker CD
    J Infect Dis; 1978 Aug; 138(2):143-51. PubMed ID: 681794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of the protease activity of Vibrio cholerae strains and mutants with various biological properties].
    Uraleva VS; Gulida MM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Sep; (9):7-10. PubMed ID: 3061263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and phenotypic characterization of virulence-deficient mutants of Vibrio cholerae.
    Baselski VS; Upchurch S; Parker CD
    Infect Immun; 1978 Oct; 22(1):181-8. PubMed ID: 730346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Potentials and conditions for the reversion of pathogenic properties of the causative agent of cholera in an experiment].
    Uraleva VS; Cherepakhina IIa; Gulida MM; Kutyreva IV; Pomukhina OI
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Dec; (12):54-9. PubMed ID: 6528781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophospholipase L2 of Vibrio cholerae O1 affects cholera toxin production.
    Whayeb SA; Yamamoto K; Castillo ME; Tojo H; Honda T
    FEMS Immunol Med Microbiol; 1996 Aug; 15(1):9-15. PubMed ID: 8871110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterisation of a non-toxinogenic mutant of V. cholerae and possibility of a live oral cholera vaccine.
    Datta A; Sasmal D; Datta GC; Pal SC
    Indian J Med Res; 1977 Jun; 65(6):770-6. PubMed ID: 604253
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect on enterotoxicity of protease purified from Vibrio cholerae O1.
    Ichinose Y; Ehara M; Honda T; Miwatani T
    FEMS Microbiol Lett; 1994 Jan; 115(2-3):265-71. PubMed ID: 8138138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of toxin biosynthesis by plasmids in Vibrio cholerae.
    Khan AA; Srivastava R; Sinha VB; Srivastava BS
    J Gen Microbiol; 1985 Oct; 131(10):2653-7. PubMed ID: 3934328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Vibrio pathogenicity island-encoded Mop protein suggests a pleiotropic role in the virulence of epidemic Vibrio cholerae.
    Zhang D; Rajanna C; Sun W; Karaolis DK
    FEMS Microbiol Lett; 2003 Aug; 225(2):311-8. PubMed ID: 12951258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions.
    Fasano A; Baudry B; Pumplin DW; Wasserman SS; Tall BD; Ketley JM; Kaper JB
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5242-6. PubMed ID: 2052603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of pathogenicity by P and V plasmids in Vibrio cholerae.
    Sinha VB; Srivastava BS
    J Gen Microbiol; 1978 Feb; 104(2):251-5. PubMed ID: 632803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of hemagglutinin/protease and motility to the pathogenesis of El Tor biotype cholera.
    Silva AJ; Leitch GJ; Camilli A; Benitez JA
    Infect Immun; 2006 Apr; 74(4):2072-9. PubMed ID: 16552036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity filters, a new approach to the isolation of tox mutants of Vibrio cholerae.
    Mekalanos JJ; Collier RJ; Romig WR
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):941-5. PubMed ID: 345281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical characterization of extracellular proteases from Vibrio cholerae.
    Young DB; Broadbent DA
    Infect Immun; 1982 Sep; 37(3):875-83. PubMed ID: 6752027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenic potential of vibrio cholerae 01 isolated from the Mapocho river and Aguada ditch].
    Herrera N; Prado V; Mamani N; Martínez J; Ojeda A
    Rev Med Chil; 1993 May; 121(5):483-8. PubMed ID: 8272626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on toxinogenesis in Vibrio cholerae. III. Characterization of nontoxinogenic mutants in vitro and in experimental animals.
    Holmes RK; Vasil ML; Finkelstein RA
    J Clin Invest; 1975 Mar; 55(3):551-60. PubMed ID: 803978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP and its receptor protein negatively regulate the coordinate expression of cholera toxin and toxin-coregulated pilus in Vibrio cholerae.
    Skorupski K; Taylor RK
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):265-70. PubMed ID: 8990197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytotoxic effect of Vibrio cholerae non-O1 on Vero cells].
    Figueroa-Arredondo P; García-Lozano H; Gutiérrez-Cogco L; Valdespino-Gómez JL
    Rev Latinoam Microbiol; 1994; 36(4):277-81. PubMed ID: 7701138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 strains: clonal relationships between clinical and environmental isolates.
    Singh DV; Matte MH; Matte GR; Jiang S; Sabeena F; Shukla BN; Sanyal SC; Huq A; Colwell RR
    Appl Environ Microbiol; 2001 Feb; 67(2):910-21. PubMed ID: 11157262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of hypotoxigenic Vibrio cholerae population by human intestinal bacteria in gnotobiotic mice.
    Watanabe S; Shimamura T; Aiba Y; Ozawa A; Sasaki S
    Tokai J Exp Clin Med; 1986 Aug; 11(3):155-62. PubMed ID: 3617104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.